Mesoblast (MESO) Share-based Compensation (QoQ) (2016 - 2023)
Mesoblast (MESO) Share-based Compensation (QoQ) (2016 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
133.56% |
| Mar 31, 2023 |
-398.01% |
| Dec 31, 2022 |
402.00% |
| Sep 30, 2022 |
-92.13% |
| Jun 30, 2022 |
168.29% |
| Mar 31, 2022 |
-354.66% |
| Dec 31, 2021 |
137.55% |
| Sep 30, 2021 |
-89.69% |
| Jun 30, 2021 |
0.00% |
| Mar 31, 2021 |
23.98% |
| Dec 31, 2020 |
169.33% |
| Sep 30, 2020 |
-368.30% |
| Jun 30, 2020 |
0.00% |
| Mar 31, 2020 |
85.00% |
| Dec 31, 2019 |
143.62% |
| Sep 30, 2019 |
-274.39% |
| Jun 30, 2019 |
150.38% |
| Mar 31, 2019 |
-415.20% |
| Dec 31, 2018 |
134.73% |
| Sep 30, 2018 |
-244.80% |
